Test Bank For Tietz Fundamentals of Clinical Chemistry and
Molecular Diagnostics, 9th Edition by Nader Rifai, All 49
Chapters Covered and Verified
,Tietz xFundamentals xof xClinical xChemistry xand xMolecular xDiagnostics x9th x Edition xTest xBank
Table xof xcontents:
I. xPrinciples xOf xLaboratory xMedicine
Chapter x1. xClinical xChemistry, xMolecular xDiagnostics, xand xLaboratory xMedicine
Chapter x2. xSelection xand xAnalytical xEvaluation xof xMethods x— xWith xStatistical xTechniques
Chapter x3. xClinical xEvaluation xof xMethods
Chapter x4. xEvidence-Based xLaboratory xMedicine
Chapter x5. xEstablishment xand xUse xof xReference xValues
Chapter x6. xSpecimen xCollection, xProcessing, xand xOther xPreanalytical xVariables
Chapter x7. xQuality xManagement
II. xAnalytical xTechniques xAnd xInstrumentation
Chapter x8. xPrinciples xof xBasic xTechniques xand xLaboratory xSafety
Chapter x9. xOptical xTechniques
Chapter x10. xElectrochemistry xand xChemical xSensors
Chapter x11. xElectrophoresis
Chapter x12. xChromatography
Chapter x13. xMass xSpectrometry
Chapter x14. xEnzyme xand xRate xAnalyses
Chapter x15. xImmunochemical xTechniques
Chapter x16 xAutomation
Chapter x17. xPoint-of-Care xInstrumentation
III. x Analytes
Chapter x18. xAmino xAcids, xPeptides, xand xProteins
Chapter x19. xSerum xEnzymes
Chapter x20. xTumor xMarkers xand xCancer xGenes
Chapter x21. xKidney xFunction xTests x— xCreatinine, xGFR, xUrea, xand xUric xAcid
Chapter x22. xCarbohydrates
Chapter x23. xLipids, xLipoproteins, xApolipoproteins, xand xOther xCardiac xRisk xFactors
Chapter x24. xElectrolytes xand xBlood xGases
Chapter x25. xHormones
Chapter x26. x Catecholamines xand xSerotonin
Chapter x27. x Vitamins, xTrace xElements, xNutritional xAssessment
Chapter x28. xHemoglobin, xIron, xand xBilirubin
Chapter x29. xPorphyrins xand xPorphyrias
Chapter x30. xTherapeutic xDrugs xand xTheir xManagement
Chapter x31. xClinical xToxicology
Chapter x32. x Toxic xMetals
IV. x Pathophysiology
Chapter x33. xDiabetes
,Chapter x34. x Cardiovascular xDisease
Chapter x35. x Kidney xDisease
Chapter x36. x Physiology xand xDisorders xof xWater, xElectrolyte, xand xAcid-Base xMetabolism
Chapter x37. x Liver xDisease
Chapter x38. x Gastrointestinal xand xPancreatic xDiseases
Chapter x39. x Disorders xof xBone xand xMineral xMetabolism
Chapter x40. x Disorders xof xthe xPituitary xGland
Chapter x41. x Disorders xof xthe xAdrenal xCortex
Chapter x42. x Thyroid xDisorders
Chapter x43. x Reproduction-Related xDisorders
Chapter x44. x Pregnancy xand xPrenatal xTesting
Chapter x45. x Newborn xScreening xand xInborn xErrors xof xMetabolism
Chapter x46. xPharmacogenetics
V. x Molecular xDiagnostics
Chapter x47. xPrinciples xof xMolecular xBiology
Chapter x48. xNucleic xAcid xTechniques xand xApplications
Chapter x49. xGenomes xand xNucleic xAcid xAlterations
, Tietz xFundamentals xof xClinical xChemistry xand xMolecularDiagnostics, x9e xBurtis xTest xBank
Chapter x01: xClinical xChemistry, xMolecular xDiagnostics, xand xLaboratory xMedicineTest
xBank
MULTIPLE xCHOICE
1. An xindividual xworking xin xa xclinical xchemistry xlaboratory xis xmarried xto xa xsales
xrepresentative xwho xworks xfor xa xcompany xthat xsells xchemistry xlaboratory xsupplies. xWhen
xthe xlaboratory xmanager xrequests xa xlist xof xneeded xsupplies, xcost xof xsupplies, xand xvendors,
xthis xindividual xonly xrecommends xthe xspouse’s xcompany xas xthe xvendor. xThis xis
xconsidered xto xbe xa(n):
a. accounting xissue.
b. possible xconflict xof xinterest.
c. maintenance xof xconfidentiality xissue.
d. problem xwith xresource xallocation.
ANS: x B
Concern xhas xbeen xraised xover xthe xinterrelationships xbetween xpractitioners xin xthe xmedical
xfield xand xcommercial xsuppliers xof xdrugs, xdevices, xequipment, xetc., xto xthe xmedical
xprofession.
Similarly, xrelationships xhave xbeen xscrutinized xbetween xclinical xlaboratorians xand
xmanufacturers xand xproviders xof xdiagnostic xequipment xand xsupplies. xThese xconcerns xled
xthe xNational xInstitutes xof xHealth x(NIH) xin x1995 xto xrequire xofficial xinstitutional xreview xof
xfinancial xdisclosure xby xresearchers xand xmanagement xof xsituations xin xwhich xdisclosure
xindicates xpotential xconflicts xof xinterest.
DIF: 1 REF: x x Page x4-5 OBJ: x 6 x| x7
2. A xpatient xvisits xher xphysician xstating xthat xher xprescribed xpainkiller xis xnot xworking xto
xreduce xthe xpain xfollowing xher xrecent xsurgery. xA xfriend xof xthe xpatient xclaims xthat xthe
xsame xpainkiller x“worked xwonders” xto xreduce xher xpain xafter xthe xsame xsurgery. xThe
xphysician xstates xthat xthe xdifference xin xthe xeffect xof xthe xdrug xmight xbe xcaused xby ,
xwhich xis xstudied xin xpharmacogenetics.
a. epidemiology
b. an xinherited xdisease
c. a xconflict xof xinterest
d. a xgenetic xvariation xin xdrug-metabolizing xenzymes
ANS: x D
Pharmacogenetics xis xthe xstudy xof xthe xgenetic xvariation xof xdrug xmetabolism xbetween
xindividuals.
DIF: 1 REF: x x Page x3 OBJ: x 1
3. John xworks xin xa xmolecular xdiagnostics xlaboratory xand xreceives xa xblood xsample xthat xhas
xthe xname xof xa xclose xfriend xprinted xon xthe xbar-coded xlabel. xThe xgenetic xtest xthat xis
xordered xon xthe xfriend’s xsample xwould xprovide xdiagnostic xinformation xabout xa xdisorder
xthat xhas xa xpoor xprognosis, xand xthe xtest xis xusually xperformed xby xJohn. xHe xasks xa xfellow
xemployee xto xanalyze xthe xsample xfor xhim xand xnot xdivulge xthe xresults. xThis xethical xissue
xconcerns:
a. confidentiality xof xpatient xgenetic xand xmedical xinformation.
b. a xconflict xof xinterest.
c. resource xallocation.
d. diagnostic xaccuracy.
Molecular Diagnostics, 9th Edition by Nader Rifai, All 49
Chapters Covered and Verified
,Tietz xFundamentals xof xClinical xChemistry xand xMolecular xDiagnostics x9th x Edition xTest xBank
Table xof xcontents:
I. xPrinciples xOf xLaboratory xMedicine
Chapter x1. xClinical xChemistry, xMolecular xDiagnostics, xand xLaboratory xMedicine
Chapter x2. xSelection xand xAnalytical xEvaluation xof xMethods x— xWith xStatistical xTechniques
Chapter x3. xClinical xEvaluation xof xMethods
Chapter x4. xEvidence-Based xLaboratory xMedicine
Chapter x5. xEstablishment xand xUse xof xReference xValues
Chapter x6. xSpecimen xCollection, xProcessing, xand xOther xPreanalytical xVariables
Chapter x7. xQuality xManagement
II. xAnalytical xTechniques xAnd xInstrumentation
Chapter x8. xPrinciples xof xBasic xTechniques xand xLaboratory xSafety
Chapter x9. xOptical xTechniques
Chapter x10. xElectrochemistry xand xChemical xSensors
Chapter x11. xElectrophoresis
Chapter x12. xChromatography
Chapter x13. xMass xSpectrometry
Chapter x14. xEnzyme xand xRate xAnalyses
Chapter x15. xImmunochemical xTechniques
Chapter x16 xAutomation
Chapter x17. xPoint-of-Care xInstrumentation
III. x Analytes
Chapter x18. xAmino xAcids, xPeptides, xand xProteins
Chapter x19. xSerum xEnzymes
Chapter x20. xTumor xMarkers xand xCancer xGenes
Chapter x21. xKidney xFunction xTests x— xCreatinine, xGFR, xUrea, xand xUric xAcid
Chapter x22. xCarbohydrates
Chapter x23. xLipids, xLipoproteins, xApolipoproteins, xand xOther xCardiac xRisk xFactors
Chapter x24. xElectrolytes xand xBlood xGases
Chapter x25. xHormones
Chapter x26. x Catecholamines xand xSerotonin
Chapter x27. x Vitamins, xTrace xElements, xNutritional xAssessment
Chapter x28. xHemoglobin, xIron, xand xBilirubin
Chapter x29. xPorphyrins xand xPorphyrias
Chapter x30. xTherapeutic xDrugs xand xTheir xManagement
Chapter x31. xClinical xToxicology
Chapter x32. x Toxic xMetals
IV. x Pathophysiology
Chapter x33. xDiabetes
,Chapter x34. x Cardiovascular xDisease
Chapter x35. x Kidney xDisease
Chapter x36. x Physiology xand xDisorders xof xWater, xElectrolyte, xand xAcid-Base xMetabolism
Chapter x37. x Liver xDisease
Chapter x38. x Gastrointestinal xand xPancreatic xDiseases
Chapter x39. x Disorders xof xBone xand xMineral xMetabolism
Chapter x40. x Disorders xof xthe xPituitary xGland
Chapter x41. x Disorders xof xthe xAdrenal xCortex
Chapter x42. x Thyroid xDisorders
Chapter x43. x Reproduction-Related xDisorders
Chapter x44. x Pregnancy xand xPrenatal xTesting
Chapter x45. x Newborn xScreening xand xInborn xErrors xof xMetabolism
Chapter x46. xPharmacogenetics
V. x Molecular xDiagnostics
Chapter x47. xPrinciples xof xMolecular xBiology
Chapter x48. xNucleic xAcid xTechniques xand xApplications
Chapter x49. xGenomes xand xNucleic xAcid xAlterations
, Tietz xFundamentals xof xClinical xChemistry xand xMolecularDiagnostics, x9e xBurtis xTest xBank
Chapter x01: xClinical xChemistry, xMolecular xDiagnostics, xand xLaboratory xMedicineTest
xBank
MULTIPLE xCHOICE
1. An xindividual xworking xin xa xclinical xchemistry xlaboratory xis xmarried xto xa xsales
xrepresentative xwho xworks xfor xa xcompany xthat xsells xchemistry xlaboratory xsupplies. xWhen
xthe xlaboratory xmanager xrequests xa xlist xof xneeded xsupplies, xcost xof xsupplies, xand xvendors,
xthis xindividual xonly xrecommends xthe xspouse’s xcompany xas xthe xvendor. xThis xis
xconsidered xto xbe xa(n):
a. accounting xissue.
b. possible xconflict xof xinterest.
c. maintenance xof xconfidentiality xissue.
d. problem xwith xresource xallocation.
ANS: x B
Concern xhas xbeen xraised xover xthe xinterrelationships xbetween xpractitioners xin xthe xmedical
xfield xand xcommercial xsuppliers xof xdrugs, xdevices, xequipment, xetc., xto xthe xmedical
xprofession.
Similarly, xrelationships xhave xbeen xscrutinized xbetween xclinical xlaboratorians xand
xmanufacturers xand xproviders xof xdiagnostic xequipment xand xsupplies. xThese xconcerns xled
xthe xNational xInstitutes xof xHealth x(NIH) xin x1995 xto xrequire xofficial xinstitutional xreview xof
xfinancial xdisclosure xby xresearchers xand xmanagement xof xsituations xin xwhich xdisclosure
xindicates xpotential xconflicts xof xinterest.
DIF: 1 REF: x x Page x4-5 OBJ: x 6 x| x7
2. A xpatient xvisits xher xphysician xstating xthat xher xprescribed xpainkiller xis xnot xworking xto
xreduce xthe xpain xfollowing xher xrecent xsurgery. xA xfriend xof xthe xpatient xclaims xthat xthe
xsame xpainkiller x“worked xwonders” xto xreduce xher xpain xafter xthe xsame xsurgery. xThe
xphysician xstates xthat xthe xdifference xin xthe xeffect xof xthe xdrug xmight xbe xcaused xby ,
xwhich xis xstudied xin xpharmacogenetics.
a. epidemiology
b. an xinherited xdisease
c. a xconflict xof xinterest
d. a xgenetic xvariation xin xdrug-metabolizing xenzymes
ANS: x D
Pharmacogenetics xis xthe xstudy xof xthe xgenetic xvariation xof xdrug xmetabolism xbetween
xindividuals.
DIF: 1 REF: x x Page x3 OBJ: x 1
3. John xworks xin xa xmolecular xdiagnostics xlaboratory xand xreceives xa xblood xsample xthat xhas
xthe xname xof xa xclose xfriend xprinted xon xthe xbar-coded xlabel. xThe xgenetic xtest xthat xis
xordered xon xthe xfriend’s xsample xwould xprovide xdiagnostic xinformation xabout xa xdisorder
xthat xhas xa xpoor xprognosis, xand xthe xtest xis xusually xperformed xby xJohn. xHe xasks xa xfellow
xemployee xto xanalyze xthe xsample xfor xhim xand xnot xdivulge xthe xresults. xThis xethical xissue
xconcerns:
a. confidentiality xof xpatient xgenetic xand xmedical xinformation.
b. a xconflict xof xinterest.
c. resource xallocation.
d. diagnostic xaccuracy.
